Related Experiment Video

Updated: Aug 14, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

New vaccines against enteric bacteria for children in less developed countries

Richard I Walker1

  • 1Division of Bacterial, Parasitic and Allergenic Products, US Food and Drug Administration, 1401 Rockville Pike (HFM-425), Rockville, MD20651-1448, USA. walkerri@cber.fda.gov

Expert Review of Vaccines
|December 24, 2005
PubMed

Insights

Developing safe vaccines against infant diarrheal diseases caused by E. coli and Shigella is crucial for less developed countries. Focused research and funding are needed to test existing whole-cell vaccine candidates for children.

Area of Science:

  • * Global Health
  • * Vaccinology
  • * Pediatric Infectious Diseases

Background:

  • * Diarrheal diseases pose a significant threat to infant survival, particularly in less developed regions.
  • * Enterotoxigenic Escherichia coli (ETEC) and Shigella are key bacterial pathogens causing severe diarrhea in children.
  • * Currently, no licensed vaccines are available for these critical enteric pathogens.

Purpose of the Study:

  • * To highlight the urgent need for multicomponent whole-bacterial cell vaccines against ETEC and Shigella.
  • * To address the barriers hindering vaccine development for children in less developed countries, including funding and focus.
  • * To emphasize the potential of existing live-attenuated and inactivated whole-cell vaccine candidates.

Main Methods:

  • * Review of existing live-attenuated and inactivated whole-cell vaccine candidates.
  • * Discussion of the necessity for coordinated clinical testing to resolve key issues in mucosal vaccination.
  • * Focus on the specific needs of pediatric populations in resource-limited settings.

Main Results:

  • * The development of whole-bacterial cell vaccines offers a promising strategy to combat diarrheal diseases.
  • * Existing vaccine candidates require further coordinated testing to assess efficacy and safety.
  • * Addressing funding gaps and prioritizing pediatric needs are essential for progress.

Conclusions:

  • * Safe and effective multicomponent vaccines against ETEC and Shigella are achievable and critically needed.
  • * Coordinated research on existing vaccine candidates can overcome major hurdles in enteric disease prevention.
  • * Successful vaccine implementation could significantly reduce the burden of diarrheal diseases on child health and productivity.

More Related Videos

A High-throughput Shigella-specific Bactericidal Assay06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...